Agios Pharmaceuticals, Inc. (AGIO)
27.86
-0.06
(-0.21%)
USD |
NASDAQ |
Mar 20, 16:00
27.86
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Research and Development Expense (Quarterly) : 86.79M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.565B |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| CorMedix, Inc. | 8.60M |
| Enanta Pharmaceuticals, Inc. | 20.86M |